Investor Overview
FAST FACTS
OUR INVESTMENT CASE
Commercial Pharmaceuticals revenue: CER
![]() |
Emerging market growth > Developed market growthon a three-year compound annual growth rate (“CAGR”) |
SENS ANNOUNCEMENTS
SHARE PRICE CENTRE
View share price information for Aspen Holdings.
SHARE CODE
APN ISIN: ZAE 000066692
JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual.
CAPITAL
DISTRIBUTIONS
All capital distributions to date
SHAREHOLDER
STATISTICS
Analysis of shareholders at 30 June 2021
CORPORATE INFORMATION
All corporate information and contact details
REGISTER FOR ALERTS
CONTACT DETAILS
Investor Relations
+27 31 580 8600
InvestorRelations@aspenpharma.com
WEBCASTS
Click to view the webcast
of our Financial Results for
the year ended 30 June 2022
1 September 2022 | 08:30 CAT
Click to view the webcast recording
of our Financial Results for
the six months ended
31 December 2021
Click to view the webcast recording
of our Financial Results for
the year ended 30 June 2021
Click to view our
Investor Day webcast of
11 December 2020
INVESTOR CALENDAR
01
March 2023
Interim results: SENS announcement
02
March 2023
Interim results presentation: In-person & livestreamed
30
August 2023
Annual results: SENS announcement
31
August 2023
Annual results presentation: In-person & livestreamed
07
December 2023
Annual General Meeting